.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: RE45573

« Back to Dashboard

Claims for Patent: RE45573

Title:Process for producing imide compound
Abstract: The present invention provides an excellent industrial process for producing an imide compound hydrochloride. The process for producing an imide compound hydrochloride of the formula (2): ##STR00001## or an enantiomer thereof, which comprises treating a compound of the formula (1): ##STR00002## or an enantiomer thereof with an aqueous hydrochloric acid solution in a hydrophilic solvent, followed by crystallizing the resultant.
Inventor(s): Kakiya; Yuzo (Ibaraki, JP), Oda; Mayumi (Osaka, JP)
Assignee: Sumitomo Dainippon Pharma Co., Ltd. (Osaka, JP)
Application Number:14/137,464
Patent Claims: 1. A process for producing an imide compound hydrochloride of the formula (2): ##STR00008## or an enantiomer thereof, which comprises treating a compound of the formula (1): ##STR00009## or an enantiomer thereof with 1.8 to 5.0% aqueous hydrochloric acid solution in acetone, crystallizing the resultant hydrochloride of the formula (2), and isolating the crystallized hydrochloride of the formula (2).

2. The process for producing the imide compound hydrochloride according to claim 1, wherein the aqueous hydrochloric acid solution is a 3.0-5.0% aqueous hydrochloric acid solution.

.Iadd.3. The imide compound hydrochloride of the formula (2) ##STR00010## which is obtained by the process according to claim 1 or 2. .Iaddend.

.Iadd.4. The imide compound hydrochloride as set forth in claim 3, which has a residual acetone content of about 0.1% by weight or less. .Iaddend.

.Iadd.5. The imide compound hydrochloride as set forth in claim 3, which has impurities of about 0.1% by weight or less. .Iaddend.

.Iadd.6. The imide compound hydrochloride as set forth in claim 3, which has a residual acetone content of about 0.1% by weight or less, and which has impurities of about 0.1% by weight or less. .Iaddend.

.Iadd.7. A process for producing an imide compound hydrochloride of the formula (2): ##STR00011## which comprises treating a compound of the formula (1): ##STR00012## with 1.8 to 5.0% aqueous hydrochloric acid solution in acetone, crystallizing the resultant hydrochloride of the formula (2), and isolating the crystallized hydrochloride of the formula (2). .Iaddend.

.Iadd.8. The process for producing the imide compound hydrochloride according to claim 7, wherein the aqueous hydrochloric acid solution is a 3.0-5.0% aqueous hydrochloric acid solution. .Iaddend.

.Iadd.9. The imide compound hydrochloride of the formula (2) ##STR00013## which is obtained by the process according to claim 7 or 8. .Iaddend.

.Iadd.10. The imide compound hydrochloride as set forth in claim 9, which has a residual acetone content of about 0.1% by weight or less. .Iaddend.

.Iadd.11. The imide compound hydrochloride as set forth in claim 9, which has impurities of about 0.1% by weight or less. .Iaddend.

.Iadd.12. The imide compound hydrochloride as set forth in claim 9, which has a residual acetone content of about 0.1% by weight or less, and which has impurities of about 0.1% by weight or less. .Iaddend.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc